Abstract Background Converging evidence suggests a role for microglia-mediated neuroinflammation in Parkinson’s disease (PD). Animal models of PD can serve as a platform to investigate the role of neuroinflammation in degeneration in PD. However, due to features of the previously available PD models, interpretations of the role of neuroinflammation as a contributor to or a consequence of neurodegeneration have remained elusive. In the present study, we investigated the temporal relationship of neuroinflammation in a model of synucleinopathy following intrastriatal injection of pre-formed alpha-synuclein fibrils (α-syn PFFS). Methods Male Fischer 344 rats (N = 114) received unilateral intrastriatal injections of α-syn PFFs, PBS, or rat serum...
Synucleinopathies are neurodegenerative disorders characterized by intracellular protein aggregates,...
Parkinson's disease (PD) is a chronic and progressive neurodegenerative disorder characterized by a ...
Immune changes in the brain and periphery in Parkinson’s disease (PD) patients have been documented,...
Neuroinflammation has become a well-accepted pathologic hallmark of Parkinson's disease (PD). Howeve...
Post-mortem analysis of brains from Parkinson's disease (PD) patients strongly supports microglia ac...
Parkinson´s disease (PD) is the most common movement disorder caused by dopamine deficiency owing to...
Previous studies demonstrate that intrastriatal injections of fibrillar alpha-synuclein (α-syn) into...
Abstract Genetic variation in a major histocompatibility complex II (MHCII)-encoding gene (HLA-DR) i...
Abstract Background The role of both microglial activation and alpha-synuclein deposition in Parkins...
Parkinson’s disease (PD) is a complex pathology causing a plethora of non-motor symptoms besides cla...
Human studies and preclinical models of Parkinson\u27s disease implicate the involvement of both the...
We investigated changes in innate and adaptive immunity paralleling the progressive nigrostriatal da...
A key pathological process in Parkinson's disease (PD) is the transneuronal spreading of α-synuclein...
Parkinson’s disease is the second most common neurodegenerative disease, characterised by α-synuclei...
Although a causative role of α-synuclein (α-syn) is well established in Parkinson’s disease pathogen...
Synucleinopathies are neurodegenerative disorders characterized by intracellular protein aggregates,...
Parkinson's disease (PD) is a chronic and progressive neurodegenerative disorder characterized by a ...
Immune changes in the brain and periphery in Parkinson’s disease (PD) patients have been documented,...
Neuroinflammation has become a well-accepted pathologic hallmark of Parkinson's disease (PD). Howeve...
Post-mortem analysis of brains from Parkinson's disease (PD) patients strongly supports microglia ac...
Parkinson´s disease (PD) is the most common movement disorder caused by dopamine deficiency owing to...
Previous studies demonstrate that intrastriatal injections of fibrillar alpha-synuclein (α-syn) into...
Abstract Genetic variation in a major histocompatibility complex II (MHCII)-encoding gene (HLA-DR) i...
Abstract Background The role of both microglial activation and alpha-synuclein deposition in Parkins...
Parkinson’s disease (PD) is a complex pathology causing a plethora of non-motor symptoms besides cla...
Human studies and preclinical models of Parkinson\u27s disease implicate the involvement of both the...
We investigated changes in innate and adaptive immunity paralleling the progressive nigrostriatal da...
A key pathological process in Parkinson's disease (PD) is the transneuronal spreading of α-synuclein...
Parkinson’s disease is the second most common neurodegenerative disease, characterised by α-synuclei...
Although a causative role of α-synuclein (α-syn) is well established in Parkinson’s disease pathogen...
Synucleinopathies are neurodegenerative disorders characterized by intracellular protein aggregates,...
Parkinson's disease (PD) is a chronic and progressive neurodegenerative disorder characterized by a ...
Immune changes in the brain and periphery in Parkinson’s disease (PD) patients have been documented,...